If you want to grow your home dialysis program then do urgent start PD. Check out the @RPANephrology white paper out on doing just this. Retweet to your fellow nephs. https://t.co/CIkWco5aNX

It is so cool seeing images of Rich standing on stage and presenting this It was only 15 years ago I sat in his clinic and we had little more than RAASi and fish oil for pts with IgA Nephropathy Now an explosion of therapies precisely targeting the mechanisms disease #KidneyWk

I told you IV iron was safe and effective. Now we have a observational evidence (propensity matched study in about 15,000 pts with MRSA infections and 27,000 with pneumonia) that it may be beneficial.

A step-by-step algorithm for the optimal assessment and management of hypertension among patients on dialysis ca. 2024 from @JASN_News @AgarwalRajivMD #Nephpearls 👉 https://t.co/FYcUlEVPFN

Sodium Bicarbonate for Severe Metabolic Acidemia and Acute Kidney InjuryThe BICARICU-2 Randomized Clinical Trial https://t.co/xkjxvcn9ko

I learned injectafer (a version of IV iron) can cause severe hypophosphatemia in as high as 50-70% of patients because it increases intact FGF23, which is a hyperphosphorylated protein. My heme attending hated injectafer.

Epoetin: From life-saving to dangerous therapy in dialysis 1989-2005 This is a clinical history of the 5th biologic protein approved by the FDA under the brand name EPOGEN. Use of epoetin had an immediately life-saving impact on management of anemia in CKD patients. 1/

Nephrology is evolving fast—AI, new care models & Medicare updates are reshaping kidney care. 💡 RPA leads with advocacy, policy engagement & innovation. Stay informed and shape the future. 🔗 https://t.co/nu7UmHysem #RPA #Nephrology

Now online in @NDTsocial Eculizumab for rapidly progressive glomerulonephritis 🧐Eculizumab, by rapidly suppressing complement attack and inflammation during the active phase of RPGN, may serve as a promising add-on therapeutic agent. ▶️ https://t.co/XBNQKAEiMQ

After the success of FLOW in the CKD DKD population exciting to see this encouraging data in ESKD GLP-1 RA use associated with: 📉 weight loss ⚖️ lower BMI 🪦 lower mortality 📜 higher chance of kidney tx waitlisting https://t.co/PBogYa5Yqt

📢 New in CJASN: pooled analysis of all completed phase 2/3 RCTs in #IgAN 🔹 4 drug classes (steroids, B-cell, complement, non-immunological) 🔹 All ↓ proteinuria ≥30% 🔹 All improved GFR slope 🔹 Biggest benefit: B-cell therapies https://t.co/NZBl0kIKZQ

That's definitely the best source in order to deeply understand acid-base in clinical practice. Highly reccomended. https://t.co/d4yzJ4IrYZ

Decongestion Secrets ("ammo" for rounds): In a multicenter study of 283 acute heart failure patients, changes in renal filtration markers (cystatin C or creatinine) with aggressive diuresis were not associated with changes in markers of renal tubular injury (NAG, NGAL, or KIM-1)

Pfizer discovered the antifungal fluconazole - a cure for candida infections and deadly fungal meningitis Pfizer discovered the tetracycline antibiotic which cures a wide range of infections Pfizer massively scaled up penicillin production and curing millions from infection

Are you using 0.9% NaCl or balanced salt solutions such as Lactated Ringer's or Plasmalyte to resuscitate your patients with DKA? This paper suggests that we should be using the latter. 🎩 tip to the authors. https://t.co/Sfr6vCn6le

Fluid accumulation syndrome, a term coined by these authors, definitely sounds nicer than "drowning your patients." Either way, stop drowning your patients. 🎩 tip to the authors, including @Manu_Malbrain https://t.co/Sfr6vCn6le

I was today years old when I learned that HHD only started in mainland China in April 2020 https://t.co/5HnjqEh8P1

🧵1/ Hypovolaemia is the most overdiagnosed concept in medicine. We say it reflexively — especially in sepsis. But here’s the uncomfortable truth: We can’t measure blood volume. We infer it. Often wrongly. Let’s unpack why that matters. 👇 #MedTwitter #FOAMed

Congratulations Dr. Michael Allon @UAB_NRTC !! 👏👏👏👏

We use diuretics every day in the ICU. Prescribing them is never a one-size-fits-all approach. This paper reviews different strategies we can utilize with our patients. 🎩 tip to the authors! https://t.co/wtiQFg1wGN

He begins by citing research that Americans pay less (on average) for unbranded drug than the OECD, and 90% of our Rx’s are generic. However, the research points out overall the US pays an astounding 278% more for drugs. There’s no justification for that, and Cowen knows that.